Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma

ClinicalTrials.gov ID: NCT02775812

Public ClinicalTrials.gov record NCT02775812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 2, 2026, 11:20 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase I trial studies the side effects and best dose of pembrolizumab when given together with cisplatin and intensity-modulated radiation therapy, in treating patients with stage III-IV squamous cell carcinoma of the head and neck. Monoclonal antibodies, such as pembrolizumab, may block tumor growth in different ways by targeting certain cells. Drugs used in chemotherapy, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Intensity-modulated radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Giving pembrolizumab with cisplatin and intensity-modulated radiation therapy may work better in treating patients with squamous cell carcinoma of the head and neck.

Study identification

NCT ID
NCT02775812
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
37 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 28, 2016 (Actual)
Primary completion
Dec 3, 2018 (Actual)
Completion
May 20, 2022 (Actual)
Last update posted
Jun 10, 2022

2016 – 2022

United States locations

U.S. sites
69
U.S. states
29
U.S. cities
61
Facility City State ZIP Site status
Banner University Medical Center - Tucson Tucson Arizona 85719 —
UC San Diego Moores Cancer Center La Jolla California 92093 —
Cedars Sinai Medical Center Los Angeles California 90048 —
Sutter Medical Center Sacramento Sacramento California 95816 —
University of Colorado Hospital Aurora Colorado 80045 —
Penrose-Saint Francis Healthcare Colorado Springs Colorado 80907 —
Poudre Valley Hospital Fort Collins Colorado 80524 —
Yale University New Haven Connecticut 06520 —
Helen F Graham Cancer Center Newark Delaware 19713 —
Christiana Care Health System-Christiana Hospital Newark Delaware 19718 —
UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables Florida 33146 —
UM Sylvester Comprehensive Cancer Center at Deerfield Beach Deerfield Beach Florida 33442 —
University of Florida Health Science Center - Gainesville Gainesville Florida 32610 —
University of Miami Miller School of Medicine-Sylvester Cancer Center Miami Florida 33136 —
Grady Health System Atlanta Georgia 30303 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 —
Rush - Copley Medical Center Aurora Illinois 60504 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
Decatur Memorial Hospital Decatur Illinois 62526 —
Methodist Medical Center of Illinois Peoria Illinois 61636 —
OSF Saint Francis Medical Center Peoria Illinois 61637 —
Carle Cancer Center Urbana Illinois 61801 —
Franciscan Health Indianapolis Indianapolis Indiana 46237 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
University of Kansas Cancer Center Kansas City Kansas 66160 —
University of Kansas Cancer Center-Overland Park Overland Park Kansas 66210 —
The James Graham Brown Cancer Center at University of Louisville Louisville Kentucky 40202 —
Ochsner Medical Center Jefferson New Orleans Louisiana 70121 —
Henry Ford Cancer Institute-Downriver Brownstown Michigan 48183 —
Henry Ford Macomb Hospital-Clinton Township Clinton Township Michigan 48038 —
Henry Ford Hospital Detroit Michigan 48202 —
Sanford Joe Lueken Cancer Center Bemidji Minnesota 56601 —
Mayo Clinic in Rochester Rochester Minnesota 55905 —
The University of Kansas Cancer Center-South Kansas City Missouri 64131 —
University of Kansas Cancer Center - North Kansas City Missouri 64154 —
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
University of New Mexico Cancer Center Albuquerque New Mexico 87102 —
Montefiore Medical Center - Moses Campus The Bronx New York 10467 —
Sanford Bismarck Medical Center Bismarck North Dakota 58501 —
Sanford Roger Maris Cancer Center Fargo North Dakota 58122 —
Case Western Reserve University Cleveland Ohio 44106 —
Cleveland Clinic Cancer Center/Fairview Hospital Cleveland Ohio 44111 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 —
Cleveland Clinic Cancer Center Independence Independence Ohio 44131 —
Cleveland Clinic Cancer Center Mansfield Mansfield Ohio 44906 —
Hillcrest Hospital Cancer Center Mayfield Heights Ohio 44124 —
UH Seidman Cancer Center at Lake Health Mentor Campus Mentor Ohio 44060 —
North Coast Cancer Care Sandusky Ohio 44870 —
Cleveland Clinic Cancer Center Strongsville Strongsville Ohio 44136 —
Cleveland Clinic Wooster Family Health and Surgery Center Wooster Ohio 44691 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Clackamas Radiation Oncology Center Clackamas Oregon 97015 —
Providence Portland Medical Center Portland Oregon 97213 —
Saint Luke's University Hospital-Bethlehem Campus Bethlehem Pennsylvania 18015 —
Christiana Care Health System-Concord Health Center Chadds Ford Pennsylvania 19317 —
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
UPMC-Shadyside Hospital Pittsburgh Pennsylvania 15232 —
Sanford USD Medical Center - Sioux Falls Sioux Falls South Dakota 57117-5134 —
UT Southwestern/Simmons Cancer Center-Dallas Dallas Texas 75390 —
University of Texas Health Science Center at San Antonio San Antonio Texas 78229 —
Huntsman Cancer Institute/University of Utah Salt Lake City Utah 84112 —
PeaceHealth Saint Joseph Medical Center Bellingham Washington 98225 —
University of Washington Medical Center - Montlake Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02775812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 10, 2022 · Synced Nov 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02775812 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →